Related Experiment Video
Updated: Mar 3, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Community-engaged clinical governance and machine learning for optimizing tuberculosis management in rural Eastern
Lindiwe Modest Faye1, Ntandazo Dlatu2, Mojisola Clara Hosu1
1School of Laboratory Medicine and Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Mthatha, South Africa.
Abstract:
Tuberculosis (TB) remains a major global health challenge, particularly in high-burden, resource-limited settings. Community-Engaged Clinical Governance (CE-CG) has emerged as a promising framework for strengthening accountability, adherence, and continuity of care by integrating clinical governance and community participation. This study examined the alignment between CE-CG implementation and TB treatment outcomes in the rural Eastern Cape, South Africa, using patient data from 2018 to 2020. Descriptive statistics, correlation analysis, and explanatory machine-learning models (logistic regression, random forest, and decision tree) were applied to address distinct research objectives, along with scenario-based projections. CE-CG was retrospectively operationalized as a binary programmatic indicator reflecting periods of structured governance implementation, including community health worker tracing, digital adherence monitoring, integrated TB-HIV care, and governance dashboard oversight. Machine-learning models were intentionally used as explanatory tools rather than predictive models to assess the internal coherence of the CE-CG framework. The observed perfect classification performance reflects deterministic alignment between governance implementation and treatment outcomes within this cohort rather than generalizable predictive accuracy. Treatment success improved substantially over the study period, increasing from 41.6% in 2018 to 68.3% in 2020. Scenario-based projections indicate that under a slow intervention trajectory (3.5% annual growth), treatment success would reach only 76.6% by 2030. In contrast, a sustained governance strategy (5.34% annual growth) could achieve the World Health Organization (WHO) target of 95%. Correlation analysis revealed a perfect positive association between CE-CG and treatment success, which was interpreted as an artifact of retrospective coding rather than a causal effect. Loss to follow-up and multidrug-resistant TB demonstrated weaker associations with outcomes, while extensively drug-resistant TB remained negatively associated. Overall, the findings support CE-CG as a policy-relevant, programmatic framework for strengthening adherence, retention, and accountability in high-burden rural TB settings. Embedding CE-CG within TB programmes offers a sustainable pathway toward achieving the WHO treatment success targets and accelerating progress toward TB elimination.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Therapeutic Drug Monitoring: Affecting Factors

